Previous studies examining the frequency of p16 mutation in esophageal cancer have focused primarily upon SCC in surgical resections, with reported frequencies of mutation ranging from 0% to 52%, with most studies reporting 15–20% [4], [14], [30]. The gene discussed is CDKN2A; the disease is esophageal cancer.